CRISPR cures progeria in mice, raising hope for one-time therapy for a disease that causes rapid aging
By Sharon Begley,
STAT
| 01. 06. 2021
Biologists tend not to discuss experimental results on a handful of cells and a single solitary mouse — too preliminary, too sketchy. David Liu of the Broad Institute therefore had no plans to present such findings, which he’d peeked at over his graduate student’s shoulder, when he gave a high-profile talk in 2018 at the National Institutes of Health on a form of the CRISPR genome-editing system that he’d invented.
Not that he wasn’t tempted. Student Luke Koblan had used the clever new form of CRISPR, called base editing, to alter a single misspelled pair of “letters” among the 3 billion in the DNA of cells taken from children with progeria, an infamous and fatal genetic disease marked by accelerated aging. Koblan had done this work in lab dishes, and had also corrected the progeria mutation in a mouse carrying the human gene that, as a result, aged so quickly that by toddlerhood, it was like a picture of Dorian Gray with whiskers.
Chatting before his talk with NIH Director Francis Collins, who discovered the progeria mutation in 2003, Liu... see more
Related Articles
By Fiona Harvey, The Guardian | 01.06.2021
By Jeffrey Mervis, Science | 01.06.2021
Low-income commuters who rely on public transit face many challenges—multiple transfers, long waits, and off-hour travel—that aren’t measured in the usual ridership surveys. Vanessa Frias-Martinez, a computer scientist at the University of Maryland, College Park, wants to ease their commute...
By Gwen D’Arcangelis, Guest Contributor
| 01.07.2021
Photo by Adrian Lange on Unsplash
Living under the COVID-19 pandemic has justifiably created fear and uncertainty about germs and their evolving contagiousness and lethality. Against the backdrop of the natural evolution of the coronavirus and emerging new strains, many ruminate over further alarming scenarios—from questions about the coronavirus’s possible lab origins, to worry over the possibility of biohackers engineering new pandemic germs. New gene editing technologies like CRISPR make these scenarios all the more frightening, as they...
By Emily Mullin, Future Human | 01.05.2021
Every day in the United States, 17 people die waiting for a lifesaving organ transplant. To address this crisis, one biotech company is turning to an unlikely source: pigs. Maryland-based United Therapeutics says it plans to begin transplanting organs from...
